Citigroup maintains a "buy" rating on CHINA RES LAND (01109) with a target price of HK$32.7.
Citigroup expects the gross profit margin of the top four self-developed projects of China Resources Land to be 10%-15%.
Citigroup released a research report stating that CHINA RES LAND (01109) is moving towards becoming a large asset management platform. The bank expects that under the "3+1" strategy, the proportion of recurring profits of CHINA RES LAND will gradually increase. Therefore, they maintain a "buy" rating with a target price of 32.7 Hong Kong dollars.
The bank pointed out that CHINA RES LAND's October mall retail same-store sales achieved positive growth, with an increase of 4%. The bank believes that CR Mixc may achieve a revenue growth of over 10% after 2025. In addition, the bank expects the gross margin of the top four self-developed projects of CHINA RES LAND to be 10%-15%; in terms of property investment, they anticipate about 10% natural growth and focus on return on invested capital (ROIC). It is expected that CHINA RES LAND plans to recover 30 billion RMB through mall REIT in the next three years.
Related Articles

CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.
CHINFMINING(01258): Regarding the tailings dam incident, Qianbi Xi wet method has already fully fulfilled the repair and governance obligations in accordance with government instructions.

A-share hot topics in the evening | NVIDIA invests $5 billion in Intel

Energizer Medicine-B (02595): Hong Kong public offering oversubscribed by 2662.79 times, net proceeds from global offering approximately 1.67 billion Hong Kong dollars.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025